GZMB and neoplasm: In the representative case (patient 3; Supplemental Table 1) with negative 68Ga-grazytracer PET/CT results after 1 cycle of pembrolizumab treatment, 68Ga-grazytracer imaging showed low tumor uptake in the whole body, indicating that there was no granzyme B secretion in any of the lesions.